Best AI Retinal Screening Software 2026: FDA-Cleared Systems Compared
Compare the top AI retinal screening software platforms for optometrists. Evaluate accuracy, workflow integration, and FDA clearance status in this 2026 guide.
Editor's picks
Eyenuk EyeArt
The only AI cleared by the FDA to detect both more-than-mild and vision-threatening DR, across multiple cameras.
Best for: Practices that want the widest clearance and freedom to use multiple retinal cameras.
Digital Diagnostics LumineticsCore
The first FDA-authorized autonomous AI diagnostic in any field of medicine, purpose-built for DR.
Best for: Primary-care and optometry settings wanting a proven, autonomous point-of-care diagnosis.
AEYE Health AEYE-DS
The only FDA-cleared autonomous DR AI that needs just one image per eye, with a portable camera.
Best for: Practices and outreach settings wanting the simplest capture with a portable camera.
How we ranked these tools
Clearance and accuracy audit
FDA clearance scope, sensitivity/specificity, camera compatibility, and autonomous vs assistive operation checked against FDA records and vendor documentation.
Workflow review
Point-of-care result speed, camera requirements, and EHR/imaging integration assessed from published deployments.
Criteria scoring
Each system scored on features (40%), ease of use (30%), and value (30%), weighted for real primary-eye-care diabetic screening.
Editorial review
Scores reconciled with clearance breadth, camera flexibility, and deployment cost.
Scores are based on three dimensions: Features (~40%), Ease of use (~30%), Value (~30%).
Comparison table
| # | Tool | Category | Score | Visit |
|---|---|---|---|---|
| 1 |
Eyenuk EyeArt
Editor's pick
|
Broadest FDA clearance | 8.8/10 | |
| 2 |
Digital Diagnostics LumineticsCore
Runner-up
|
First FDA-authorized | 8.7/10 | |
| 3 |
AEYE Health AEYE-DS
Also great
|
Portable single-image | 8.7/10 |
Autonomous AI has quietly become real clinical infrastructure in eye care: three FDA-cleared systems can now diagnose diabetic retinopathy from a fundus image at the point of care, without a physician reviewing the picture. For optometry and primary care, that means catching sight-threatening disease earlier and billing for the screening. This guide scores the FDA-cleared AI retinal-screening systems on accuracy, workflow, and clearance scope.
What to Look for in AI Retinal Screening
- FDA clearance scope: confirm exactly what a system is cleared to detect — more-than-mild DR, vision-threatening DR, or both — and for which camera.
- Autonomous vs assistive: autonomous systems return a diagnosis without physician image review; assistive tools flag findings for a clinician to confirm.
- Camera compatibility: some AI is camera-agnostic across manufacturers, while others are cleared only with a specific camera — this shapes your hardware choice and cost.
- Capture simplicity: fewer images per eye and portable-camera support lower technician training and speed throughput.
- Workflow and billing: point-of-care results and clean EHR/imaging integration determine whether screening actually fits a busy clinic and gets reimbursed.
How to Choose
If you want the broadest clearance and freedom to use cameras you already own, EyeArt is the most flexible choice. If you want the longest-proven autonomous diagnosis with a defined primary-care workflow, LumineticsCore is the pioneer. If your priority is the simplest capture — one image per eye on a portable camera for tight spaces or community outreach — AEYE-DS stands out. In every case, verify the exact FDA-cleared indication and camera pairing, and model the per-screen economics against your diabetic patient volume and reimbursement.
The 3 best options, reviewed
Eyenuk EyeArt
Best for: Practices that want the widest clearance and freedom to use multiple retinal cameras.
Standout feature: The only AI cleared by the FDA to detect both more-than-mild and vision-threatening DR, across multiple cameras.
Eyenuk's EyeArt is the most flexible autonomous AI here: it is the only system FDA-cleared to detect both more-than-mild and vision-threatening diabetic retinopathy, and it works with multiple retinal cameras from different manufacturers rather than locking you to one. That clearance breadth and camera flexibility make it the strongest fit for most practices adding autonomous DR screening.
Pros
- FDA-cleared for both more-than-mild and vision-threatening DR
- Camera-agnostic across manufacturers
- Autonomous, point-of-care result
- Strong published accuracy
Cons
- Requires a compatible fundus camera
- Per-screen economics need volume to justify
Digital Diagnostics LumineticsCore
Best for: Primary-care and optometry settings wanting a proven, autonomous point-of-care diagnosis.
Standout feature: The first FDA-authorized autonomous AI diagnostic in any field of medicine, purpose-built for DR.
LumineticsCore (formerly IDx-DR) from Digital Diagnostics was, in 2018, the first FDA-authorized autonomous AI diagnostic system in any field of medicine. It makes a diabetic-retinopathy diagnosis at the point of care without physician image review, with a mature deployment track record in primary-care and optometry settings, paired with a specified fundus camera.
Pros
- First FDA-authorized autonomous AI diagnostic
- Point-of-care diagnosis without physician review
- Mature, well-studied deployments
- Clear primary-care workflow
Cons
- Tied to a specified camera setup
- Focused on DR diagnosis scope
AEYE Health AEYE-DS
Best for: Practices and outreach settings wanting the simplest capture with a portable camera.
Standout feature: The only FDA-cleared autonomous DR AI that needs just one image per eye, with a portable camera.
AEYE Health's AEYE-DS is the newest FDA-cleared autonomous DR system and the most capture-efficient: it requires just a single image per eye and is the only one cleared for a portable camera, which makes it especially attractive for space-constrained practices and community screening. Its simplicity lowers technician training and speeds throughput.
Pros
- Only one image per eye required
- Cleared for a portable camera
- Fast, simple capture and low training
- Strong for outreach and constrained spaces
Cons
- Newest entrant with a shorter track record
- Cleared with specific camera pairings
Frequently asked questions
Tools featured in this list
Showing 3 sources.
